IMPACT OF BASELINE ANGIOEDEMA AND IGE ON RESPONSE TO OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA

被引：0
|
作者：
Casale, T.
Trzaskoma, B.
Holden, M.
Bernstein, J.
Maurer, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P073
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] Omalizumab in chronic spontaneous urticaria
    Martin Marques, Marta
    De Dios Lopez, Anna
    Jornet Montana, Sonia
    Sanchez Parada, Lucia
    Lopez Broseta, Pilar Ana
    del Estal Jimenez, Jorge
    Canela Subirada, Montserrat
    Canadell Vilarrasa, Laura
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 223 - 223
  • [22] Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria
    Keskinkaya, Zeynep
    Kaya, Ozge
    Mermutlu, Selda Isik
    Ogretmen, Zerrin
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (08) : 786 - 793
  • [23] Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria
    Costa, Celia
    Caldeira, Leonor Esteves
    Paulino, Marisa
    Santos, Diana F.
    Silva, Susana L.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (03) : 260 - 266
  • [24] Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab
    Watanabe, Haruka
    Takahagi, Shunsuke
    Hayama, Koremasa
    Fukunaga, Atsushi
    Nakagawa, Yukinobu
    Inomata, Naoko
    Chinuki, Yuko
    Hide, Michihiro
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [25] Omalizumab treatment response in patients with chronic spontaneous urticaria
    Knezevic, Sandra
    Dujmovic-Hasanbegovic, Katarina
    Peternel, Sandra
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 377 - 378
  • [26] Four-week total IgE/baseline total IgE ratio: Biomarker for omalizumab good response in chronic spontaneous urticaria real-life patients
    Caldeira, Leonor Esteves
    Bernardino, Ana
    Paulino, Marisa
    Costa, Celia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (12): : 3808 - 3811
  • [27] High IgG Anti-IgE Autoantibodies Prevent Early Omalizumab Response in Chronic Spontaneous Urticaria
    Niwa, Yusuke
    Hayama, Koremasa
    Toyoshima, Shota
    Shimizu, Keisuke
    Tagui, Maho
    Ito, Mana
    Sakamoto, Tomomi
    Terui, Tadashi
    Fujita, Hideki
    Okayama, Yoshimichi
    ALLERGY, 2024,
  • [28] Elevated IgE to tissue factor and thyroglobulin are abated by omalizumab in chronic spontaneous urticaria
    Cugno, Massimo
    Asero, Riccardo
    Ferrucci, Silvia
    Lorini, Maurizio
    Carbonelli, Vincenzo
    Tedeschi, Alberto
    Marzano, Angelo V.
    ALLERGY, 2018, 73 (12) : 2408 - 2411
  • [29] Elevated baseline soluble FceRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria
    Monino-Romero, S.
    Kolkhir, P.
    Ohanyan, T.
    Szepfalusi, Z.
    Weller, K.
    Metz, M.
    Scheffel, J.
    Maurer, M.
    Altrichter, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : 167 - 174
  • [30] Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema
    Maurer, M.
    Sofen, H.
    Ortiz, B.
    Kianifard, F.
    Gabriel, S.
    Bernstein, J. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (06) : 1056 - 1063
12345